30 July 2025
: Case report 
Successful Management of Severe Refractory ARDS in Hemophagocytic Lymphohistiocytosis with VV-ECMO: A Case Report and Analysis
Challenging differential diagnosis, Management of emergency care, Rare disease
Mengqi Guan BCDE 1,2, Yan Qian C 3, Zihua Tang F 1,2, Yingya Cao C 1,2,4, Xiaogan Jiang ADG 1,2, Weihua Lu ACG 1,2*, Qiancheng Xu A 1,2,4DOI: 10.12659/AJCR.949154
Am J Case Rep 2025; 26:e949154
Figure 3 Trends in platelet count, hemoglobin, white blood cell count, and oxygenation index over timeThe progression of platelet count (A), hemoglobin levels (B), white blood cell count (C), and oxygenation index (D) over time. Two key treatment milestones are marked: the administration of methylprednisolone (1 g daily for 5 days) starting on May 6, 2021, and the initiation of etoposide-based chemotherapy on February 20, 2021. The duration of veno-venous extracorporeal membrane oxygenation support is indicated from February 2, 2021, to February 10, 2021, and mechanical ventilation support was provided from February 1, 2021, to February 22, 2021.